The Federal Antimonopoly Service (FAS) of Russia has agreed on the maximum selling price of the drug for the treatment of coronavirus “Kovidolek”. The price of a package of 40 tablets will be 2,916 rubles.
“FAS has agreed on the maximum selling price of the drug” Covidolek “… The price for a package of 40 tablets of 200 mg will be 2,916 rubles,” the service said (quoted by RIA Novosti).
The tool is included in the list of vital and essential medicines, it “has an antiviral effect and is used in the treatment of COVID-19.” The third phase of clinical trials of Covidolek (favipiravir) began in March this year. It is produced by Nanolek. Completion of clinical trials is scheduled for December 31, 2022.
About the progress achieved in the treatment of COVID-19 – in the material “b”.
.